Covance will acquire Merck‘s Seattle-based Gene Expression Laboratory in exchange for a $145 million, five-year supply agreement with Merck for genomic analysis services. The lab performs genomics services such as genotyping, gene sequencing and gene expression profiling. “The acquisition of this laboratory brings world-class talent and technologies to Covance and further expands our capabilities in genomics testing and personalized medicine,” said Joe Herring, chairman and ...